| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |